Breaking News
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details

Top 5 Things to Know in the Market on Monday, June 8th

EconomyJun 08, 2020 12:23
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

By Peter Nurse 

Investing.com -- ECB head Christine Lagarde will face a grilling about the latest largess from the central bank, while Wall Street is set to open higher, continuing the recent positive trend. Crude oil posted more gains as major producers agreed to limit output for another month, while speculation has emerged about a huge meger in the healthcare sector. Here’s what you need to know in financial markets on Monday, June 8th.

1. ECB head Lagarde faces questions

All eyes will be on European Central Bank head Christine Lagarde later Monday as she testifies, via satellite link, before the European Parliament Economic and Monetary Affairs Committee.

Lawmakers will have the opportunity to ask questions about the reasons behind the ECB’s larger-than-expected increase in its emergency bond buying stimulus program. Investors will be looking for clues on whether the ECB plans to ease monetary policy even further.

The ECB padded its emergency bond-buying fund by another 600 billion euros ($680 billion) at its meeting last Thursday, and it’s easy to see why given the depth of the region’s slowdown illustrated by the almost 18% slump in Germany’s industrial production data in April.

However, she could face some tricky questions over this additional stimulus after the German top court ruling that the European Central Bank abused its power in earlier bond purchases.

2. Talk of mega-healthcare merger

AstraZeneca (NYSE:AZN), the British-Swedish pharmaceutical giant, approached U.S. rival Gilead Sciences (NASDAQ:GILD) about a potential tie-up last month, according to a report by Bloomberg over the weekend.

Such a deal would result in the biggest healthcare merger to date, creating a partnership worth around 200 billion pounds ($250 billion).

The two companies are among a host of firms racing to develop a vaccine for Covid-19, while Gilead’s antiviral drug Remdesivir is seen as a leading treatment for patients suffering from the effects of the virus.

Both companies have declined to comment on the report, but doubts exist as to the likelihood of this tie-up now as AstraZeneca’s valuation could soar given its collaboration with researchers at Oxford University put it at the forefront of the search for a vaccine.

3. OPEC+ agrees extension to record production cuts

Crude oil prices pushed higher Monday after a group of major producers agreed to extend a deal on record output cuts to the end of July.

Sentiment in the oil market has changed sharply since the Organization of the Petroleum Exporting Countries and its allies, including Russia - collectively known as OPEC+ - agreed in April to cut supply by 9.7 million barrels per day during May-June to prop up prices that collapsed due to the coronavirus crisis.

On Saturday, the group agreed to extend the deal by a third month to the end of July. 

The extension had been delayed by the worries of some of the bigger producers, namely Saudi Arabia and Russia, that other countries were playing fast and loose with compliance.

Iraq and Nigeria exceeded production quotas in May and June, but they have agreed to slightly deeper cuts to compensate for their failure to the original agreement.

Investor sentiment also got a boost from Sunday’s Chinese customs data which indicated that the country’s crude imports soared to 11.34 barrels a day, 15% more than April, a positive indication of China’s recovery from the Covid-19 virus.

By 6:30 AM ET, U.S. crude futures were up 0.8% at $39.68 a barrel, while the global benchmark Brent was up 1.2% at $42.82 a barrel.

4. Stocks set to open higher, continuing recent gains 

U.S. stock markets are set to open higher, continuing to push higher as optimism grows about the rebounding of the economy from the shutdown needed to combat the Covid-19  virus.

By 6:30 AM (1030 GMT), the Dow Jones 30 futures contract was up 141 points or 0.5%, while the S&P 500 futures contract was up 0.4% and the Nasdaq 100 futures contract was up 0.1%.

The Dow Jones Industrial Average and S&P 500 cash indices are now trading at 3.5 month highs, having posted gains for three straight weeks, while the NASDAQ Composite posted an all-time intraday high on Friday.

Friday’s shock gain in payrolls has boosted hope of a V-shaped economic recovery. Adding to the positive news is that New York City, seen as the epicenter of the virus outbreak in the U.S., is to begin its phase one reopening  Monday.

This all puts the spotlight on the U.S. Federal Reserve's monetary policy announcement on Wednesday. 

5. Musk doubles down on SpaceX

Elon Musk is in the spotlight again. 

Fresh from his SpaceX company launching astronauts for the first time just a few days ago, Musk has urged his SpaceX employees to accelerate progress on its next-generation Starship rocket “dramatically and immediately,” in a company-wide email seen by CNBC.

Musk’s goal is to make Starship fully reusable, becoming more like a commercial airplane with short turnaround times between flights, making it more commercially viable.

This is all very exciting, but is there a danger Musk loses focus regarding his Tesla (NASDAQ:TSLA) electric car company?

 

Top 5 Things to Know in the Market on Monday, June 8th
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email